Foong K, Loh P, Chaw S, Lo Y
Pharm Res. 2025; .
PMID: 40021547
DOI: 10.1007/s11095-025-03835-1.
van Valkengoed D, Krekels E, Knibbe C
Clin Pharmacokinet. 2024; 64(2):173-192.
PMID: 39644458
PMC: 11782306.
DOI: 10.1007/s40262-024-01444-6.
Kurup S, Velez de Mendizabal N, Becker S, Bolella E, De Sousa D, Fatkenheuer G
J Pharmacokinet Pharmacodyn. 2024; 52(1):3.
PMID: 39636474
PMC: 11621205.
DOI: 10.1007/s10928-024-09947-2.
Hughes J, Amin N, Wojciechowski J, Vourvahis M
CPT Pharmacometrics Syst Pharmacol. 2024; 14(2):317-330.
PMID: 39564924
PMC: 11812935.
DOI: 10.1002/psp4.13275.
Blouin M, Metras M, Gaudreault C, Dube M, Boulanger M, Cloutier K
Pharmacotherapy. 2024; 44(12):907-919.
PMID: 39544156
PMC: 11687215.
DOI: 10.1002/phar.4623.
Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimus.
Fan L, Guo H, Zhao Y, Li Y, Wang W, Huang J
Front Pharmacol. 2024; 15:1457614.
PMID: 39380905
PMC: 11458483.
DOI: 10.3389/fphar.2024.1457614.
Pharmacometrics-Enhanced Bayesian Borrowing for Pediatric Extrapolation - A Case Study of the DINAMO Trial.
Sailer M, Neubacher D, Johnston C, Rogers J, Wiens M, Perez-Pitarch A
Ther Innov Regul Sci. 2024; 59(1):112-123.
PMID: 39373938
PMC: 11706882.
DOI: 10.1007/s43441-024-00707-5.
Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery.
Wu R, Li K, Zhao Z, Mei S
Eur J Clin Pharmacol. 2024; 80(11):1819-1828.
PMID: 39210212
DOI: 10.1007/s00228-024-03746-x.
Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?.
Nardotto G, Svenson E, Bollela V, Rocha A, Slavov S, Ximenez J
Pharmaceutics. 2024; 16(8).
PMID: 39204315
PMC: 11359463.
DOI: 10.3390/pharmaceutics16080970.
Population pharmacokinetics of total and unbound valemetostat and platelet dynamics in healthy volunteers and patients with non-Hodgkin lymphoma.
Fukae M, Baron K, Tachibana M, Mondick J, Shimizu T
CPT Pharmacometrics Syst Pharmacol. 2024; 13(10):1641-1654.
PMID: 39077926
PMC: 11494923.
DOI: 10.1002/psp4.13201.
Population pharmacokinetic modeling of sufentanil in adult Korean patients undergoing cardiopulmonary bypass surgery.
Khaowroongrueng V, Son K, Lee S, Lee J, Park C, Lee S
CPT Pharmacometrics Syst Pharmacol. 2024; 13(10):1682-1692.
PMID: 39039947
PMC: 11494824.
DOI: 10.1002/psp4.13205.
Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens.
Tan Z, Voller S, Yin A, Rieborn A, Gelderblom A, van der Hulle T
Clin Pharmacokinet. 2024; 63(6):857-869.
PMID: 38874883
PMC: 11222182.
DOI: 10.1007/s40262-024-01379-y.
Meropenem Disposition in Neonatal and Pediatric Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.
Pokorna P, Michalickova D, Tibboel D, Berner J
Antibiotics (Basel). 2024; 13(5).
PMID: 38786147
PMC: 11117356.
DOI: 10.3390/antibiotics13050419.
Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?.
El Hassani M, Liebchen U, Marsot A
Eur J Drug Metab Pharmacokinet. 2024; 49(4):419-436.
PMID: 38705941
DOI: 10.1007/s13318-024-00897-1.
A systematic evaluation of population pharmacokinetic models for polymyxin B in patients with liver and/or kidney dysfunction.
Li X, Cheng Y, Zhang B, Chen B, Chen Y, Huang Y
J Pharmacokinet Pharmacodyn. 2024; 51(6):685-702.
PMID: 38625507
DOI: 10.1007/s10928-024-09916-9.
Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants.
McCann S, Helfer V, Balevic S, Hornik C, Goldstein S, Autmizguine J
J Clin Pharmacol. 2024; 64(8):963-974.
PMID: 38545761
PMC: 11286355.
DOI: 10.1002/jcph.2434.
When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?.
Wu Y, Allegaert K, Flint R, Goulooze S, Valitalo P, de Hoog M
Pharm Res. 2024; 41(4):637-649.
PMID: 38472610
PMC: 11024008.
DOI: 10.1007/s11095-024-03677-3.
and Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach.
Mohammed Ali Z, Meertens M, Fernandez B, Fontova P, Vidal-Alabro A, Rigo-Bonnin R
Pharmaceutics. 2023; 15(12).
PMID: 38140040
PMC: 10747255.
DOI: 10.3390/pharmaceutics15122699.
Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
Le Blanc J, Projean D, Savignac S, Leveille S, Ducas M, Brisebois-Boyer A
Clin Pharmacokinet. 2023; 63(2):183-196.
PMID: 38127240
DOI: 10.1007/s40262-023-01329-0.
New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model.
Rodriguez-Fernandez K, Reynaldo-Fernandez G, Reyes-Gonzalez S, de Las Barreras C, Rodriguez-Vera L, Vlaar C
Biomed Pharmacother. 2023; 170:115977.
PMID: 38056237
PMC: 10853672.
DOI: 10.1016/j.biopha.2023.115977.